Black men have lower preference for investigation of prostate cancer
the ONA take:
According to a recent study published in the British Journal of General Practice, researchers from University of Exeter Medical School in Exeter, United Kingdom, have found that black men are less willing to be investigated for prostate cancer, thereby increasing the likelihood of being diagnosed as emergencies and having a higher mortality rate compared with white men.
For the study, researchers identified over 500 men attending general practices in Bristol, United Kingdom, and presented them with realistic hypothetical scenarios in which the participants was given a description of a prostate cancer symptom and the estimated risk of prostate cancer.
Results showed that black men were less likely to prefer investigation of the symptom despite the risk given in the scenario. Researchers found that when participants were presented with scenarios associated with the lowest risk level, only 44% of black males opted for investigation versus 91% of white males.
Among both groups, the most common reason for choosing not to investigate the symptom was low risk, but significantly more black participants reported that they did not want to know if they had cancer.
The findings suggest that health care professionals should proactively discuss the subject of cancer with their patients and education targeted at the black community may help reduce fear of cancer investigation.
Black men are less willing to be investigated for prostate cancer, thereby increasing the likelihood of being diagnosed.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|